fluconazole has been researched along with Brain Inflammation in 8 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Currently, cancer patients with microbial infection are a severe challenge in clinical treatment." | 1.72 | Synthesis of Hemiprotonic Phenanthroline-Phenanthroline ( Cui, Z; Fu, A; Fu, C; Keerthiga, R; Li, X; Tong, T; Yang, X; Zhang, Y; Zhao, Z, 2022) |
| "Fluconazole was administered intravenously at average multiple doses of 12." | 1.33 | Pharmacokinetics of fluconazole in the cerebrospinal fluid of children with hydrocephalus. ( Bafeltowska, JJ; Buszman, E, 2005) |
| "neoformans in the brains and lungs of MAIDS mice, the pathogen grew in the brains of MAIDS mice treated with fluconazole." | 1.31 | Lanoconazole, a new imidazole antimycotic compound, protects MAIDS mice against encephalitis caused by Cryptococcus neoformans. ( Furukawa, K; Pollard, RB; Sasaki, H; Suzuki, F, 2000) |
| "Persons with hemophilia who receive multiple blood product transfusions from blood banks with little or no screening for infectious agents are at particularly high risk for infections with both HIV and T." | 1.29 | Successful treatment of Trypanosoma cruzi encephalitis in a patient with hemophilia and AIDS. ( Acuña, G; Brengues, C; Cuny, G; Labarca, J; Muñoz, S; Oddó, D; Saavedra, H; Sepúlveda, C; Solari, A; Veas, F, 1993) |
| "The patient died from the Cryptococcus infection on day 74 of the antimycotic therapy." | 1.29 | [Lethal meningeal encephalitis from Cryptococcus neoformans var. neoformans in a girl without serious immunodeficiency]. ( Blaschke-Hellmessen, R; Kabus, M; Kaulen, F; Schwarze, R; Wendisch, J, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, Z | 1 |
| Li, X | 1 |
| Cui, Z | 1 |
| Tong, T | 1 |
| Zhang, Y | 2 |
| Yang, X | 1 |
| Keerthiga, R | 1 |
| Fu, C | 1 |
| Fu, A | 1 |
| Modica, S | 1 |
| Miracco, C | 1 |
| Cusi, MG | 1 |
| Tordini, G | 1 |
| Muzii, VF | 1 |
| Iacoangeli, F | 1 |
| Nocentini, C | 1 |
| Ali, IKM | 1 |
| Roy, S | 1 |
| Cerase, A | 1 |
| Zanelli, G | 1 |
| De Luca, A | 1 |
| Montagnani, F | 1 |
| Martínez, DY | 1 |
| Seas, C | 1 |
| Bravo, F | 1 |
| Legua, P | 1 |
| Ramos, C | 1 |
| Cabello, AM | 1 |
| Gotuzzo, E | 1 |
| Bafeltowska, JJ | 1 |
| Buszman, E | 1 |
| Solari, A | 1 |
| Saavedra, H | 1 |
| Sepúlveda, C | 1 |
| Oddó, D | 1 |
| Acuña, G | 1 |
| Labarca, J | 1 |
| Muñoz, S | 1 |
| Cuny, G | 1 |
| Brengues, C | 1 |
| Veas, F | 1 |
| Wendisch, J | 1 |
| Blaschke-Hellmessen, R | 1 |
| Kaulen, F | 1 |
| Schwarze, R | 1 |
| Kabus, M | 1 |
| Furukawa, K | 1 |
| Sasaki, H | 1 |
| Pollard, RB | 1 |
| Suzuki, F | 1 |
| Taillan, B | 1 |
| Ferrari, E | 1 |
| Cosnefroy, JY | 1 |
| Gari-Toussaint, M | 1 |
| Michiels, JF | 1 |
| Paquis, P | 1 |
| Lefichoux, Y | 1 |
| Dujardin, P | 1 |
8 other studies available for fluconazole and Brain Inflammation
| Article | Year |
|---|---|
Synthesis of Hemiprotonic Phenanthroline-Phenanthroline
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antineoplastic Agents; Apo | 2022 |
Non-granulomatous cerebellar infection by Acanthamoeba spp. in an immunocompetent host.
Topics: Acanthamoeba; Adult; Amebiasis; Antiprotozoal Agents; Cerebellum; Dominican Republic; Encephalitis; | 2018 |
Successful treatment of Balamuthia mandrillaris amoebic infection with extensive neurological and cutaneous involvement.
Topics: Adult; Aged; Albendazole; Amebiasis; Amoebozoa; Antiprotozoal Agents; Brain; Child; Child, Preschool | 2010 |
Pharmacokinetics of fluconazole in the cerebrospinal fluid of children with hydrocephalus.
Topics: Adolescent; Antifungal Agents; Chromatography, High Pressure Liquid; Drug Monitoring; Encephalitis; | 2005 |
Successful treatment of Trypanosoma cruzi encephalitis in a patient with hemophilia and AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Chagas Disease; Dr | 1993 |
[Lethal meningeal encephalitis from Cryptococcus neoformans var. neoformans in a girl without serious immunodeficiency].
Topics: Adolescent; Amphotericin B; Antifungal Agents; Antigens, Fungal; Cryptococcosis; Cryptococcus neofor | 1996 |
Lanoconazole, a new imidazole antimycotic compound, protects MAIDS mice against encephalitis caused by Cryptococcus neoformans.
Topics: Animals; Antifungal Agents; Brain; Cryptococcosis; Cryptococcus neoformans; Cytokines; Encephalitis; | 2000 |
Favourable outcome of blastomycosis of the brain stem with fluconazole and flucytosine treatment.
Topics: Administration, Oral; Adult; Blastomyces; Blastomycosis; Brain Stem; Drug Therapy, Combination; Ence | 1992 |